Atyr Pharma Inc (LIFE)’s valuation ratios: A closer look

The closing price of Atyr Pharma Inc (NASDAQ: LIFE) was $2.00 for the day, up 4.44% from the previous closing price of $1.91. In other words, the price has increased by $+0.0850 from its previous closing price. On the day, 1200701 shares were traded.

Ratios:

Our analysis of LIFE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.27 and its Current Ratio is at 6.27. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.15.

On October 12, 2021, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $22.

On September 21, 2021, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $19.Piper Sandler initiated its Overweight rating on September 21, 2021, with a $19 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 06 ’24 when Broadfoot Jill Marie sold 1,590 shares for $1.69 per share. The transaction valued at 2,687 led to the insider holds 20,821 shares of the business.

Shukla Sanjay bought 12,000 shares of LIFE for $14,136 on Dec 12 ’23. The President and CEO now owns 106,173 shares after completing the transaction at $1.18 per share. On Dec 11 ’23, another insider, Shukla Sanjay, who serves as the President and CEO of the company, bought 3,000 shares for $1.17 each. As a result, the insider paid 3,510 and bolstered with 94,173 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LIFE now has a Market Capitalization of 135.50M and an Enterprise Value of 52.43M. For the stock, the TTM Price-to-Sale (P/S) ratio is 387.14 while its Price-to-Book (P/B) ratio in mrq is 1.40. Its current Enterprise Value per Revenue stands at 148.52 whereas that against EBITDA is -1.00.

Stock Price History:

Over the past 52 weeks, LIFE has reached a high of $2.70, while it has fallen to a 52-week low of $1.08. The 50-Day Moving Average of the stock is 1.7797, while the 200-Day Moving Average is calculated to be 1.6642.

Shares Statistics:

LIFE traded an average of 528.14K shares per day over the past three months and 716.42k shares per day over the past ten days. A total of 67.75M shares are outstanding, with a floating share count of 65.34M. Insiders hold about 3.56% of the company’s shares, while institutions hold 60.45% stake in the company. Shares short for LIFE as of Feb 29, 2024 were 108.23k with a Short Ratio of 0.55, compared to 99.41k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.18% and a Short% of Float of 0.27%.

Earnings Estimates

The firm’s stock currently is rated by 5 analysts. On average, analysts expect EPS of -$0.24 for the current quarter, with a high estimate of -$0.18 and a low estimate of -$0.29, while EPS last year was -$0.29. The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.19 and low estimates of -$0.3.

Analysts are recommending an EPS of between -$0.75 and -$1.19 for the fiscal current year, implying an average EPS of -$0.94. EPS for the following year is -$0.95, with 4 analysts recommending between -$0.64 and -$1.11.

Most Popular